Adherence to Statins and LDL-Cholesterol Goal Attainment

被引:0
|
作者
Chi, Margaret D. [1 ]
Vansomphone, Southida S. [2 ]
Liu, In-Lu Amy [1 ]
Cheetham, T. Craig [2 ]
Green, Kelley R. [3 ]
Scott, Ronald D. [4 ]
Reynolds, Kristi [1 ]
机构
[1] Kaiser Permanente So Calif, Dept Res & Evaluat, Pasadena, CA 91101 USA
[2] Kaiser Permanente, Pharm Analyt Serv, Downey, CA USA
[3] Kaiser Permanente So Calif, Permanente Med Grp, Pasadena, CA 91101 USA
[4] Kaiser Permanente So Calif, West Los Angeles Med Ctr, Los Angeles, CA USA
来源
AMERICAN JOURNAL OF MANAGED CARE | 2014年 / 20卷 / 04期
关键词
LONG-TERM PERSISTENCE; HEART-DISEASE; MYOCARDIAL-INFARCTION; SECONDARY PREVENTION; CORONARY; THERAPY; STROKE; ASSOCIATION; UPDATE;
D O I
暂无
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Objectives: To examine the relationship between low-density lipoprotein cholesterol (LDL-C) goal attainment and adherence to statin medications in patients with coronary artery disease (CAD). Study Design: Cross-sectional study of CAD patients 18 years of age or older in an integrated healthcare system. Methods: Patients dispensed 2 or more statin prescriptions between May 2009 and May 2010, were identified. Medication possession ratio (MPR) was calculated to estimate adherence. The LDL-C value closest to May 27, 2010, was used to determine goal. Adherence and LDL-C goal were defined as 80% or greater MPR and less than 100 mg/dL or less than 70 mg/dL, respectively. Electronic medical records were used to identify patient demographics and clinical information. Logistic regression was used to estimate the effect of these factors on goal attainment. Results: A total of 67,100 CAD patients were identified. Overall, 85.8% had LDL-C less than 100 mg/dL, 32.4% had LDL less than 70 mg/dL, and 79.8% were adherent to their statin medication. Over 65% of patients not at LDL-C goal less than 100 mg/dL were adherent. Among patients with LDL-C less than 100 mg/dL, 17.9% were not adherent. Increasing medication adherence was associated with improved LDL-C levels. Adherence to statins, male sex, Asian and Hispanic race/ethnicity, a higher number of concurrent prescriptions, higher Charlson Comorbidity Index, and hypertension were associated with LDL-C goal attainment. Conclusions: Incorporating LDL-C levels and medication adherence at the point of care allows providers to focus interventions to address either adherence challenges or the need for medication titration in an effort to improve LDL-C goal attainment and ultimately reduce morbidity and mortality.
引用
收藏
页码:E105 / E112
页数:8
相关论文
共 50 条
  • [41] LDL-Cholesterol in secondary prevention: Goal-attainment in patients on lipid-lowering drugs in private practice and in hospitals in Austria (ZIEL)
    Foeger, Bernhard
    Patsch, Josef R.
    WIENER KLINISCHE WOCHENSCHRIFT, 2011, 123 (1-2) : 21 - 27
  • [42] STATIN UTILISATION AND LDL-CHOLESTEROL GOAL ATTAINMENT IN VERY HIGH CARDIOVASCULAR RISK PATIENTS: INSIGHTS FROM AN ITALIAN GENERAL PRACTICE POPULATION
    Gorcyca, K.
    Tomic, R.
    Paizis, G.
    Chin, J.
    Sanchez, R.
    Khan, I.
    CARDIOLOGY, 2015, 132 : 56 - 57
  • [43] COMPARISON OF NON-HDL AND LDL-CHOLESTEROL GOAL ATTAINMENT IN A LARGE, MULTINATIONAL PATIENT POPULATION: THE LIPID TREATMENT ASSESSMENT PROJECT 2
    Santos, R.
    Waters, D.
    Messig, M.
    Tarasenko, L.
    Jukema, J.
    Chiang, C-W
    Ferrieres, J.
    Verdejo, J.
    ATHEROSCLEROSIS SUPPLEMENTS, 2009, 10 (02)
  • [44] LDL-cholesterol: The lower the better
    Pedro-Botet, Juan
    Pinto, Xavier
    CLINICA E INVESTIGACION EN ARTERIOSCLEROSIS, 2019, 31 : 16 - 27
  • [45] Statins do not meet expectations for LDL-cholesterol lowering when used in clinical practice
    Frolkis, JP
    Sprecher, DL
    Pearce, GL
    CIRCULATION, 2000, 102 (18) : 874 - 874
  • [46] A cost-effectiveness model of alternative statins to achieve target LDL-cholesterol levels
    Maclaine, GDH
    Patel, H
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2001, 55 (04) : 243 - 249
  • [47] A comparison of non-HDL and LDL cholesterol goal attainment in the CHILLAS trial
    Yu, Bi-lian
    Zhao, Shui-ping
    Peng, Dao-quan
    Huo, Yong
    Hu, Lu
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 168 (04) : 4340 - 4342
  • [48] IS IT NECESSARY TO CALCULATE LDL-CHOLESTEROL
    DRYGAS, J
    OSBURG, K
    JOURNAL OF CLINICAL CHEMISTRY AND CLINICAL BIOCHEMISTRY, 1980, 18 (10): : 751 - 751
  • [49] The role of ezetimibe in LDL cholesterol goal attainment in very high risk patients
    Mikhailidis, Dimitri P.
    Lawson, Richard W.
    McCormick, Anna-Louise
    Sibbring, Gillian C.
    Tershakovec, Andrew M.
    Davies, Glenn M.
    Tunceli, Kaan
    CURRENT MEDICAL RESEARCH AND OPINION, 2011, 27 (10) : 1961 - 1961
  • [50] Statin Adherence and Treatment LDL-Cholesterol Response in Type 2 Diabetes Patients
    de Vries, Dianna
    Voorham, Jaco
    Hak, Eelko
    Denig, Petra
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2014, 23 : 322 - 323